GSK signs up gene-editing pioneers in drug discovery alliance
British drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of California, in a boost to its prospects for developing new drugs.
from Reuters: Health News https://reut.rs/2KfLOm9
http://bit.ly/2zwRqiM